Current price is less than the intrinsic value

Intrinsic Value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Stocks in news: eMudhra, Tata Elxsi, Bata India, RVNL, Bharat Dynamics, Venus Remedies, HFCL and more

Stocks in news: eMudhra, Tata Elxsi, Bata India, RVNL and more

Stocks in news: LIC, IRCTC, Nykaa, Adani Enterprises, United Spirits, Glenmark Pharmaceuticals, Ethos, M&M, Venus Remedies, Inox Wind, Hindustan Copper, JSW Steel and more

Stocks in news: LIC, Nykaa, IRCTC, Adani Enterprises and more

The Panchkula-based company also reported a 16.81 per cent increase in operating profit, which went up from Rs 53.78 crore last fiscal to Rs 62.82 crore in 2021-22.

Venus Remedies registers 9.22% growth in sales for FY 2021-22

Venus Remedies registers 9.22 per cent growth in sales for FY 2021-22 | The Financial Express

The company has launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the cause

Venus Remedies dispatches first batch of essential medicines to Ukraine

Venus Remedies Ltd, KBC Global Ltd, 3P Land Holdings Ltd and Prabhat Technologies (India) Ltd are among the other losers in the BSE’s ‘B’ group today, 18 April 2022.

G G Engineering Ltd leads losers in ‘B’ group

Som Distilleries & Breweries Ltd, Venus Remedies Ltd, New Delhi Television Ltd and Tainwala Chemicals & Plastics (India) Ltd are among the other gainers in the BSE’s ‘B’ group today, 16 March 2022.

Sagar Cements Ltd leads gainers in ‘B’ group

Venus Remedies rose 3.79% to Rs 282.25 after the company said it won WHO Good Distribution Practices (GDP) certification for quality services across entire supply chain.

Venus Remedies gallops on winning WHO GDP certification

AMR Industry Alliance is the largest private-sector coalition working towards curbing AMR through a coordinated and multipronged response

Pharma company Venus Remedies joins AMR Industry Alliance

IFB Agro Industries Ltd, SPS Finquest Ltd, Madras Fertilizers Ltd and Keynote Financial Services Ltd are among the other losers in the BSE’s ‘B’ group today, 01 February 2022.

Venus Remedies Ltd leads losers in ‘B’ group

Venus Remedies consolidated net profit declines 51.54% in the December 2021 quarter

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Venus Remedies Ltd

Venus Remedies Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks in news: eMudhra, Tata Elxsi, Bata India, RVNL and more

Stocks in news: LIC, Nykaa, IRCTC, Adani Enterprises and more

Venus Remedies registers 9.22% growth in sales for FY 2021-22

Venus Remedies registers 9.22 per cent growth in sales for FY 2021-22 | The Financial Express

Venus Remedies dispatches first batch of essential medicines to Ukraine

G G Engineering Ltd leads losers in ‘B’ group

Sagar Cements Ltd leads gainers in ‘B’ group

Venus Remedies Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks in news: eMudhra, Tata Elxsi, Bata India, RVNL and more

Stocks in news: LIC, Nykaa, IRCTC, Adani Enterprises and more

Venus Remedies registers 9.22% growth in sales for FY 2021-22

Venus Remedies registers 9.22 per cent growth in sales for FY 2021-22 | The Financial Express

Venus Remedies dispatches first batch of essential medicines to Ukraine

G G Engineering Ltd leads losers in ‘B’ group

Sagar Cements Ltd leads gainers in ‘B’ group

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock